Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




FDA Panel Says No to Sodium Oxybate for Fibromyalgia
Link ID 28021
Title FDA Panel Says No to Sodium Oxybate for Fibromyalgia
Url http://www.medscape.com/viewarticle/727273?src=rss
Description A joint FDA advisory committee has voted against approval of sodium oxybate for fibromyalgia. Medscape Medical News
Category Articles > Rheumatology
Keywords
Date Aug 23, 2010
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Rheumatology
1. Hyperuricemia, Gout, and the Metabolic Syndrome
  Clinicians should be aware of the presence of metabolic syndrome in patients with hyperuricemia or gout in order to reduce the risk for cardiovascular disease.
Current Opinion in Rheumatology
Category:   Articles > Rheumatology


2. Spondyloarthropathy Treatment Linked With Change in Body Composition
  Spondyloarthropathy patients who receive anti-tumor necrosis factor (TNF) therapy experience significant changes in body composition, according to a report in the May issue of The Journal of Rheumatology. Reuters Health Information
Category:   Articles > Rheumatology


3. Rituximab May Be Best Choice After Anti-TNF Fail in RA Rituximab May Be Best Choice After Anti-TNF F
  If a first TNF inhibitor fails to control rheumatoid arthritis adequately, registry data suggest that switching to B-cell depletion might have more effect than trying a second anti-TNF therapy. Medscape Medical News
Category:   Articles > Rheumatology


4. Diabetes and Rheumatic Diseases
  What is the recent progress made in understanding the interactions between diabetes and common musculoskeletal syndromes, two diseases that exert significant healthcare cost and burden on society?
Current Opinion in Rheumatology
Category:   Articles > Rheumatology


5. Golimumab Shows Promise Against Rheumatoid Arthritis
  Golimumab, a new human anti-TNF alpha antibody, appears beneficial in patients with active rheumatoid arthritis (RA), researchers report in a January 28th online paper in Arthritis and Rheumatism. Reuters Health Information
Category:   Articles > Rheumatology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS